Research and Development

Showing 15 posts of 9573 posts found.

UCB's new biologics research centre in Slough

UCB opens new UK biologics research centre

July 8, 2009 Research and Development UCB

 UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …

Sanofi moves to quell Lantus safety concerns

July 7, 2009 Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …

Depression warnings for Chantix and Zyban

July 7, 2009 Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …

Roche’s ABPI exit – a deliberate snub?

July 3, 2009 Research and Development, Sales and Marketing ABPI, Roche

 By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …

Asia Pacific vaccines market requires flexible, targeted portfolios

July 2, 2009 Research and Development, Sales and Marketing Asia, vaccines

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …

Onglyza and Cimzia recommended by CHMP

July 2, 2009 Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …

Pfizer halts Sutent colon cancer trial

July 2, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

Roche quits ABPI

June 30, 2009 Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

Is the law good for your health?

June 30, 2009 Research and Development Les Rose, law, science

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …

Bayer signs deal with Celera on cancer targets

June 30, 2009 Research and Development, Sales and Marketing Bayer, Celera

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …

PPD backs away from new facility lease

June 30, 2009 Research and Development CRO, PPD

PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …

Contract research sector: news in brief

June 29, 2009 Research and Development CRO, chiltern

Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …

Novartis gains approval for first Japanese biosimilar

June 25, 2009 Research and Development, Sales and Marketing Novartis, generics

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …
The Gateway to Local Adoption Series

Latest content